Selvita S.A. (WSE:SLV)

Market Cap	618.58M -21.6%
Revenue (ttm)	371.13M +7.3%
Net Income	813.00K
EPS	0.04
Shares Out	18.36M
PE Ratio	760.86
Forward PE	27.18
Dividend	n/a
Ex-Dividend Date	n/a

Volume	70,713
Average Volume	54,646
Open	33.50
Previous Close	33.00
Day's Range	32.55 - 33.80
52-Week Range	26.50 - 49.40
Beta	0.15
RSI	37.86
Earnings Date	Mar 31, 2026

About Selvita

Selvita S.A. operates as a contract research organization worldwide. The company offers drug discovery services in the areas of AI-driven drug discovery, antibody drug discovery, structural biology, recombinant protein production, assay development and screening, computer-aided drug design, medicinal and synthetic chemistry, scale-up, ADME/DMPK, in vitro and In Vivo pharmacology, translational research, and toxicology. It also develops drugs for therapeutic areas, such as oncology, infectious diseases, immunology, neurology, respiratory, and ot...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 2007
• Employees: 969
• Stock Exchange: Warsaw Stock Exchange
• Ticker Symbol: SLV